Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

GlaxoSmithKline plc Stock

Price
Target price
€17.56

€17.56

-1.720%
-0.308
-1.720%
€20.50

€20.50

 
Latest predictions
-
03.08.20
€20.00
01.08.20
buy
-
20.07.20
buy
€21.00
07.06.20
buy
€29.50
20.08.18
buy
€16.53
01.12.17
buy
Your prediction

GlaxoSmithKline plc Stock

We can see a decrease in the price for GlaxoSmithKline plc. Compared to yesterday it has lost -€0.308 (-1.720%).
Currently there is a rather positive sentiment for GlaxoSmithKline plc with 5 Buy predictions and 1 Sell predictions.
As a result the target price of €20.00 shows a slightly positive potential of 13.921% compared to the current price of €17.56 for GlaxoSmithKline plc.

Comments

Buy GlaxoSmithKline plc

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about GlaxoSmithKline plc Stock

Trading GlaxoSmithKline plc

Trading GlaxoSmithKline plc

New thread Forum

News

GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer


GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data from an updated analysis of the GARNET trial, which demonstrated that dostarlimab, an investigational anti-programmed death-1 (PD-1)